How to buy Mounjaro stock legally and safely in the UK

Free clinical consultation included (no upfront fees, no hidden charges at any stage
Your answers are read and assessed the same day by a GPhC-registered Independent Prescriber, not automated software
Once approved, orders placed before 12pm Monday to Friday are dispatched the same day from our GPhC-registered UK pharmacy
Free next-working-day tracked delivery by DPD, in plain unbranded packaging) no subscription, no auto-renewal

The only legal route to buying Mounjaro stock in the UK is through a valid prescription, issued after a clinical assessment by a registered prescriber. NICE's appraisal of tirzepatide confirms it as a clinically significant medicine for weight management — one that requires proper medical oversight, not a checkout basket. If you're looking at how to buy stock in Mounjaro through a regulated online pharmacy, the process is more straightforward than many people expect, and this page walks through every step. These are prescription-only medicines; a qualified prescriber decides whether they're right for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The clinical evidence behind Mounjaro, and what it means for accessing it

What NICE's approval tells us about getting Mounjaro through a legitimate route

NICE formally recommended tirzepatide for weight management in December 2024, publishing guidance (TA1026) based on substantial clinical trial evidence. In the SURMOUNT-1 trial, involving 2,539 adults with obesity, participants at the highest dose saw an average body-weight reduction of around 20–21% over 72 weeks — a figure the NICE committee treated as clinically meaningful when setting eligibility criteria. That approval matters for anyone trying to buy Mounjaro stock, because it shapes exactly who prescribers can lawfully treat.

Under NICE TA1026, adults with a BMI of 35 or above alongside at least one weight-related condition (such as high blood pressure, type 2 diabetes, obstructive sleep apnoea, dyslipidaemia or cardiovascular disease) qualify for consideration. Lower BMI thresholds apply for certain ethnic backgrounds under UK guidance. In private practice, licensed eligibility extends to adults with a BMI of 30 or above, or 27 or above with a qualifying condition. None of those numbers guarantee a prescription; the prescriber assesses the full clinical picture every time.

The evidence base is why the medicine sits behind a prescription gate in the first place. NICE's appraisal of tirzepatide (TA1026) lays out the trial data and the conditions of use plainly. It's worth reading if you want to understand what a prescriber is weighing up when they review your consultation.

The step-by-step route to buying Mounjaro stock from a regulated UK pharmacy

Start by completing a clinical consultation, at nume, this is free and takes place online. A GPhC-registered Independent Prescriber reads your responses personally; your case doesn't pass through a screening algorithm. Identity is verified with photo ID, and weight is confirmed on a live video call. That combination matters: it's what separates a genuine clinical assessment from a rubber-stamp process.

If the prescriber determines that treatment is clinically suitable, a prescription is issued and your order moves to our GPhC-registered UK pharmacy for dispensing. Orders confirmed before 12pm on a weekday go out the same day. Your pen arrives via DPD the next working day, tracked, in packaging that gives nothing away on the outside. Once you're established on treatment, every repeat order is clinically reviewed again before anything is dispensed, no automatic renewals, no doses sent without a prescriber seeing your update.

For anyone thinking about stocking up on Mounjaro ahead of time, it's worth knowing that clinical review sits at the start of every order for a reason. Our prescribers need current information (recent weight, any new symptoms, how the current dose is sitting) before authorising the next supply. That's the model that keeps it safe.

You can verify that any online pharmacy is properly registered by checking the GPhC register directly at GPhC registration number 9012878, that's our pharmacy's listing. The same register lets you check any provider you're considering.

Fake Mounjaro pens: what the MHRA's warnings mean for buyers

The MHRA has issued repeated public warnings about counterfeit weight-loss injection pens being sold online and through social media. In October 2025, enforcement teams raided the first illicit UK manufacturing site producing fake tirzepatide pens, and across 2025 roughly 20 million doses of illegally traded weight-loss medicines (with a street value around £45 million) were seized. Some counterfeit pens seized in earlier operations contained insulin rather than the labelled medicine, causing serious harm.

The pattern is consistent: sellers offering these medicines without a prescription, prices well below what licensed supply costs, discount codes from unrecognised sources, no verifiable GPhC registration. Those are the signals to walk away from. If you come across a seller you're uncertain about, you can report them through the MHRA's Yellow Card scheme, which accepts reports about both suspect adverse effects and suspect suppliers.

Buying through a GPhC-registered pharmacy with a verified prescriber review isn't just a legal formality. It's the only way to know the pen in your fridge door contains what the label says it does. For more background on buying Mounjaro online safely, including what to look for in a provider, that page covers the key checks in detail.

Current stock and availability: what to do if your dose isn't available

Mounjaro availability in the UK has been subject to supply pressures since the medicine's launch, with some doses more readily available than others at different times. Eli Lilly has continued to scale UK supply, and the picture has improved since 2023, though it remains worth checking before you order. Our prescribers are aware of current stock positions and can advise at consultation.

If a specific strength is tight, the right conversation is with a prescriber, not a decision to source it from an unverified seller. Mounjaro stock availability is something we update regularly, and our clinical team can discuss options if your usual dose has a lead time. For anyone currently on 5mg, the 5mg stock page has the most current position; the same applies at higher doses, where 10mg availability is tracked separately.

If you've heard that supply is disrupted and are wondering what to do, what to do when Mounjaro is out of stock explains the options clearly, including the clinical guidance on pausing and restarting. The short answer is: don't switch source; do talk to your prescriber.

Ready to get started? Check your eligibility with a free consultation and our team will take it from there.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions